429 related articles for article (PubMed ID: 25053441)
1. Axillary reverse mapping in breast cancer: a Canadian experience.
Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
[TBL] [Abstract][Full Text] [Related]
2. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
3. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
[TBL] [Abstract][Full Text] [Related]
4. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
[TBL] [Abstract][Full Text] [Related]
5. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
[TBL] [Abstract][Full Text] [Related]
6. Axillary reverse mapping: five-year experience.
Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients.
Casabona F; Bogliolo S; Valenzano Menada M; Sala P; Villa G; Ferrero S
Ann Surg Oncol; 2009 Sep; 16(9):2459-63. PubMed ID: 19506954
[TBL] [Abstract][Full Text] [Related]
8. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
11. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
13. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
[TBL] [Abstract][Full Text] [Related]
14. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
Ikeda K; Ogawa Y; Komatsu H; Mori Y; Ishikawa A; Nakajima T; Oohira G; Tokunaga S; Fukushima H; Inoue T
World J Surg Oncol; 2012 Nov; 10():233. PubMed ID: 23116152
[TBL] [Abstract][Full Text] [Related]
18. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
Seyednejad N; Kuusk U; Wiseman SM
Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
[TBL] [Abstract][Full Text] [Related]
19. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
